Osteoboost

Targeted Vibration Therapy for Better Bone Health

Description

Osteoboost is the only FDA De Novo-cleared wearable device for low bone density - a vibration belt clinically shown to slow down the decline in vertebral bone strength and bone mineral density. Prescribed to post-menopausal women with osteopenia, it works passively during daily activity and pairs with an app for usage tracking and exercise programs.

Product

No items found.

Our Investment Thesis

  • Sole FDA-cleared device in an underserved indication: Osteopenia sits in a therapeutic gap - calcium and weight-bearing exercise are the main recommendations, while medications are reserved for osteoporosis and carry serious side effects. Osteoboost is the only regulated, evidence-backed option.
  • Tailwinds from longevity and prevention: Rising focus on healthy aging, early intervention, and non-pharmacological solutions positions Osteoboost well - a low-risk, at-home device that fits naturally into daily life.
  • Preventing the downstream cascade: Post-menopausal women face accelerated bone loss; slowing that decline preserves bone strength and mineral density, key markers of fracture risk, which carries serious morbidity and mortality consequences in this population.

CEO

Laura Yecies

Location

San Francisco, USA

Website

Visit Site

Theme

#SelfCare
#PreventiveCare
AgeWell